Knight C G, Morton L F, Onley D J, Peachey A R, Ichinohe T, Okuma M, Farndale R W, Barnes M J
Biochemistry Department, Cambridge University, UK.
Cardiovasc Res. 1999 Feb;41(2):450-7. doi: 10.1016/s0008-6363(98)00306-x.
Peptides consisting of a repeat Gly-Pro-Hyp sequence are potent platelet agonists. The aim of this study was: (1) to examine the specificity of this sequence for platelet activation; (2) to confirm its recognition by platelet glycoprotein VI; and (3) to assess with suitable peptides the relative importance of glycoprotein VI and integrin alpha 2 beta 1 in platelet activation by collagen.
Peptides were synthesized by standard Fmoc chemistry and tested for their ability to support adhesion of human platelets and HT 1080 cells, induce platelet aggregation, bind integrin alpha 2 subunit A-domain and to cause tyrosine phosphorylation of platelet proteins.
(1) Peptides consisting of a repeat Gly-Pro-Pro, Gly-Pro-Ala or Gly-Pro-Arg sequence exhibited little if any platelet-reactivity. (2) The platelet-reactive peptide consisting of a repeating Gly-Pro-Hyp sequence failed to induce tyrosine phosphorylation in glycoprotein VI-deficient platelets. Platelet adhesion to this peptide was inhibited by intact anti-glycoprotein VI antibody and its Fab fragment. The latter inhibited aggregation by the peptide and fibres of both collagens I and III. (3) A peptide containing a 15-mer alpha 2 beta 1-binding sequence in a repeat Gly-Pro-Pro structure supported alpha 2 beta 1-mediated platelet and HT 1080 cell adhesion and bound alpha 2 A-domain, but failed to activate platelets or to induce tyrosine phosphorylation. Conversely, a peptide containing this sequence but with an essential Glu replaced by Ala and inserted in a repeat Gly-Pro-Hyp structure did not recognize alpha 2 beta 1, but was highly platelet activatory.
Platelet activation by collagen involves the highly-specific recognition of the Gly-Pro-Hyp sequence by platelet glycoprotein VI. Recognition of alpha 2 beta 1 is insufficient to cause activation. Interaction between collagen and glycoprotein VI is unique since Gly-Pro-Hyp is common in collagens but occurs rarely in other proteins, and glycoprotein VI may be expressed solely by platelets. This sequence could provide a basis for a highly-specific anti-thrombotic reagent to control thrombosis associated with plaque rupture.
由重复的甘氨酸-脯氨酸-羟脯氨酸序列组成的肽是有效的血小板激动剂。本研究的目的是:(1)研究该序列对血小板活化的特异性;(2)确认其被血小板糖蛋白VI识别;(3)用合适的肽评估糖蛋白VI和整合素α2β1在胶原诱导血小板活化中的相对重要性。
通过标准的Fmoc化学方法合成肽,并测试其支持人血小板和HT 1080细胞黏附、诱导血小板聚集、结合整合素α2亚基A结构域以及引起血小板蛋白酪氨酸磷酸化的能力。
(1)由重复的甘氨酸-脯氨酸-脯氨酸、甘氨酸-脯氨酸-丙氨酸或甘氨酸-脯氨酸-精氨酸序列组成的肽几乎没有血小板反应性。(2)由重复的甘氨酸-脯氨酸-羟脯氨酸序列组成的血小板反应性肽在糖蛋白VI缺陷的血小板中未能诱导酪氨酸磷酸化。完整的抗糖蛋白VI抗体及其Fab片段可抑制血小板对该肽的黏附。后者可抑制该肽以及I型和III型胶原纤维诱导的聚集。(3)在重复的甘氨酸-脯氨酸-脯氨酸结构中包含15聚体α2β1结合序列的肽支持α2β1介导的血小板和HT 1080细胞黏附并结合α2 A结构域,但未能激活血小板或诱导酪氨酸磷酸化。相反,包含该序列但一个关键的谷氨酸被丙氨酸取代并插入重复的甘氨酸-脯氨酸-羟脯氨酸结构中的肽不能识别α2β1,但具有高度的血小板激活作用。
胶原诱导的血小板活化涉及血小板糖蛋白VI对甘氨酸-脯氨酸-羟脯氨酸序列的高度特异性识别。对α2β1的识别不足以引起活化。胶原与糖蛋白VI之间的相互作用是独特的,因为甘氨酸-脯氨酸-羟脯氨酸在胶原中常见但在其他蛋白质中很少出现,并且糖蛋白VI可能仅由血小板表达。该序列可为控制与斑块破裂相关的血栓形成的高度特异性抗血栓试剂提供基础。